TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Clinical trial NCT04561986 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04561986
- Sponsor
- Vastra Gotaland Region
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2028-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.